https://www.taxtmi.com/news?id=33002 ICMR has issued an expression of interest inviting eligible organisations and manufacturers to collaborate on development of an indigenous human vaccine candidate against avian influenza H5N1, using mRNA or traditional platforms. The notice frames such vaccine development as a critical medical countermeasure to address zoonotic risk, reduce morbidity and mortality, and strengthen pandemic preparedness, noting complementary needs for surveillance, public awareness, and health infrastructure and the availability of well characterised H5N1 strains at a national virology institute for research. en-us Wed, 05 Feb 2025 18:01:03 +0530 Wed, 05 Feb 2025 18:01:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=33002 ICMR has issued an expression of interest inviting eligible organisations and manufacturers to collaborate on development of an indigenous human vaccine candidate against avian influenza H5N1, using mRNA or traditional platforms. The notice frames such vaccine development as a critical medical countermeasure to address zoonotic risk, reduce morbidity and mortality, and strengthen pandemic preparedness, noting complementary needs for surveillance, public awareness, and health infrastructure and the availability of well characterised H5N1 strains at a national virology institute for research. News - Wed, 05 Feb 2025 18:01:03 +0530 https://www.taxtmi.com/news?id=33002